Literature DB >> 28661939

Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease.

Hyung J Ahn1, Zu-Lin Chen, Daria Zamolodchikov, Erin H Norris, Sidney Strickland.   

Abstract

PURPOSE OF REVIEW: To review the evidence that the Alzheimer peptide β-amyloid interacts with the blood coagulation system and influences the pathophysiology of the disease. RECENT
FINDINGS: β-amyloid can interact with fibrinogen and blood coagulation factor XII and trigger ischemia and inflammation.
SUMMARY: β-amyloid interacts with fibrinogen and factor XII. These interactions can lead to increased clotting, abnormal clot formation, persistent fibrin deposition, and generation of proinflammatory molecules. These events can damage neurons and could contribute to the cognitive decline in Alzheimer's disease patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28661939      PMCID: PMC5540762          DOI: 10.1097/MOH.0000000000000368

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  53 in total

1.  A phase 1 study investigating DX-2930 in healthy subjects.

Authors:  Yung Chyung; Bradley Vince; Ryan Iarrobino; Dan Sexton; Jon Kenniston; Ryan Faucette; Chris TenHoor; Leslie E Stolz; Chris Stevens; Joseph Biedenkapp; Burt Adelman
Journal:  Ann Allergy Asthma Immunol       Date:  2014-06-26       Impact factor: 6.347

2.  Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain.

Authors:  K Hultman; M Cortes-Canteli; A Bounoutas; A T Richards; S Strickland; E H Norris
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

3.  Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.

Authors:  Zu-Lin Chen; Alexey S Revenko; Pradeep Singh; A Robert MacLeod; Erin H Norris; Sidney Strickland
Journal:  Blood       Date:  2017-02-27       Impact factor: 22.113

Review 4.  Clearance systems in the brain-implications for Alzheimer disease.

Authors:  Jenna M Tarasoff-Conway; Roxana O Carare; Ricardo S Osorio; Lidia Glodzik; Tracy Butler; Els Fieremans; Leon Axel; Henry Rusinek; Charles Nicholson; Berislav V Zlokovic; Blas Frangione; Kaj Blennow; Joël Ménard; Henrik Zetterberg; Thomas Wisniewski; Mony J de Leon
Journal:  Nat Rev Neurol       Date:  2015-07-21       Impact factor: 42.937

5.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 6.  Selective vulnerability in brain hypoxia.

Authors:  J Cervós-Navarro; N H Diemer
Journal:  Crit Rev Neurobiol       Date:  1991

7.  In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues.

Authors:  I B Kingston; M J Castro; S Anderson
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

8.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Authors:  Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.

Authors:  Pedro Pesini; Virginia Pérez-Grijalba; Inmaculada Monleón; Mercè Boada; Lluís Tárraga; Pablo Martínez-Lage; Itziar San-José; Manuel Sarasa
Journal:  Int J Alzheimers Dis       Date:  2012-08-16

Review 10.  Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.

Authors:  C J Westmark; D K Sokol; B Maloney; D K Lahiri
Journal:  Mol Psychiatry       Date:  2016-08-30       Impact factor: 15.992

View more
  20 in total

1.  Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.

Authors:  Pradeep K Singh; Masanori Kawasaki; Hanna E Berk-Rauch; Goushi Nishida; Takeshi Yamasaki; Michael A Foley; Erin H Norris; Sidney Strickland; Kazuyoshi Aso; Hyung Jin Ahn
Journal:  Biochemistry       Date:  2018-02-09       Impact factor: 3.162

2.  Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.

Authors:  Keith W VanDusen; Yi-Ju Li; Victor Cai; Ashley Hall; Sarah Hiles; J Will Thompson; M Arthur Moseley; Mary Cooter; Leah Acker; Jerrold H Levy; Kamrouz Ghadimi; Quintin J Quiñones; Michael J Devinney; Stacey Chung; Niccolò Terrando; Eugene W Moretti; Jeffrey N Browndyke; Joseph P Mathew; Miles Berger
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  The protective effect of early dietary fat consumption on Alzheimer's disease-related pathology and cognitive function in mice.

Authors:  Anna Amelianchik; Jonathan Merkel; Premkumar Palanisamy; Shigeru Kaneki; Emily Hyatt; Erin H Norris
Journal:  Alzheimers Dement (N Y)       Date:  2021-05-25

Review 4.  No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biol Rev Camb Philos Soc       Date:  2018-03-25

Review 5.  Fibrinogen αC domain: Its importance in physiopathology.

Authors:  Jeannette Soria; Shahsoltan Mirshahi; Sam Qiumars Mirshahi; Remi Varin; Linda L Pritchard; Claudine Soria; Massoud Mirshahi
Journal:  Res Pract Thromb Haemost       Date:  2019-02-15

6.  A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.

Authors:  Nicholas J Ashton; Alejo J Nevado-Holgado; Imelda S Barber; Steven Lynham; Veer Gupta; Pratishtha Chatterjee; Kathryn Goozee; Eugene Hone; Steve Pedrini; Kaj Blennow; Michael Schöll; Henrik Zetterberg; Kathryn A Ellis; Ashley I Bush; Christopher C Rowe; Victor L Villemagne; David Ames; Colin L Masters; Dag Aarsland; John Powell; Simon Lovestone; Ralph Martins; Abdul Hye
Journal:  Sci Adv       Date:  2019-02-06       Impact factor: 14.136

Review 7.  ApoE4: an emerging therapeutic target for Alzheimer's disease.

Authors:  Mirna Safieh; Amos D Korczyn; Daniel M Michaelson
Journal:  BMC Med       Date:  2019-03-20       Impact factor: 8.775

8.  The Alzheimer's comorbidity phenome: mining from a large patient database and phenome-driven genetics prediction.

Authors:  Chunlei Zheng; Rong Xu
Journal:  JAMIA Open       Date:  2018-12-19

9.  Amelioration of Cognitive and Behavioral Deficits after Traumatic Brain Injury in Coagulation Factor XII Deficient Mice.

Authors:  Christian Stetter; Simon Lopez-Caperuchipi; Sarah Hopp-Krämer; Michael Bieber; Christoph Kleinschnitz; Anna-Leena Sirén; Christiane Albert-Weißenberger
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

10.  Design of Diarylheptanoid Derivatives as Dual Inhibitors Against Class IIa Histone Deacetylase and β-amyloid Aggregation.

Authors:  Liang-Chieh Chen; Hui-Ju Tseng; Chang-Yi Liu; Yun-Yi Huang; Cheng-Chung Yen; Jing-Ru Weng; Yeh-Lin Lu; Wen-Chi Hou; Tony E Lin; I-Horng Pan; Kuo-Kuei Huang; Wei-Jan Huang; Kai-Cheng Hsu
Journal:  Front Pharmacol       Date:  2018-07-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.